166 related articles for article (PubMed ID: 16697155)
1. Boosting support vector regression in QSAR studies of bioactivities of chemical compounds.
Zhou YP; Jiang JH; Lin WQ; Zou HY; Wu HL; Shen GL; Yu RQ
Eur J Pharm Sci; 2006 Jul; 28(4):344-53. PubMed ID: 16697155
[TBL] [Abstract][Full Text] [Related]
2. A robust boosting regression tree with applications in quantitative structure-activity relationship studies of organic compounds.
Jiao J; Tan SM; Luo RM; Zhou YP
J Chem Inf Model; 2011 Apr; 51(4):816-28. PubMed ID: 21417261
[TBL] [Abstract][Full Text] [Related]
3. QSAR models for phosphoramidate prodrugs of 2'-methylcytidine as inhibitors of hepatitis C virus based on PSO boosting.
Cheng Z; Zhang Y; Zhou C
Chem Biol Drug Des; 2011 Dec; 78(6):948-59. PubMed ID: 21895985
[TBL] [Abstract][Full Text] [Related]
4. Prediction of toxicity of nitrobenzenes using ab initio and least squares support vector machines.
Niazi A; Jameh-Bozorghi S; Nori-Shargh D
J Hazard Mater; 2008 Mar; 151(2-3):603-9. PubMed ID: 17630186
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of QSAR/QSPR correlations using support vector machines, radial basis function neural networks, and multiple linear regression.
Yao XJ; Panaye A; Doucet JP; Zhang RS; Chen HF; Liu MC; Hu ZD; Fan BT
J Chem Inf Comput Sci; 2004; 44(4):1257-66. PubMed ID: 15272833
[TBL] [Abstract][Full Text] [Related]
6. Simultaneously optimized support vector regression combined with genetic algorithm for QSAR analysis of KDR/VEGFR-2 inhibitors.
Sun M; Chen J; Cai J; Cao M; Yin S; Ji M
Chem Biol Drug Des; 2010 May; 75(5):494-505. PubMed ID: 20486936
[TBL] [Abstract][Full Text] [Related]
7. Feature selection and linear/nonlinear regression methods for the accurate prediction of glycogen synthase kinase-3beta inhibitory activities.
Goodarzi M; Freitas MP; Jensen R
J Chem Inf Model; 2009 Apr; 49(4):824-32. PubMed ID: 19338295
[TBL] [Abstract][Full Text] [Related]
8. QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling.
Li J; Lei B; Liu H; Li S; Yao X; Liu M; Gramatica P
J Comput Chem; 2008 Dec; 29(16):2636-47. PubMed ID: 18484640
[TBL] [Abstract][Full Text] [Related]
9. QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.
Dong X; Jiang C; Hu H; Yan J; Chen J; Hu Y
Eur J Med Chem; 2009 Oct; 44(10):4090-7. PubMed ID: 19497644
[TBL] [Abstract][Full Text] [Related]
10. Global, local and novel consensus quantitative structure-activity relationship studies of 4-(Phenylaminomethylene) isoquinoline-1, 3 (2H, 4H)-diones as potent inhibitors of the cyclin-dependent kinase 4.
Lei B; Xi L; Li J; Liu H; Yao X
Anal Chim Acta; 2009 Jun; 644(1-2):17-24. PubMed ID: 19463556
[TBL] [Abstract][Full Text] [Related]
11. Piecewise hypersphere modeling by particle swarm optimization in QSAR studies of bioactivities of chemical compounds.
Lin WQ; Jiang JH; Shen Q; Wu HL; Shen GL; Yu RQ
J Chem Inf Model; 2005; 45(3):535-41. PubMed ID: 15921443
[TBL] [Abstract][Full Text] [Related]
12. QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.
Sun M; Zheng Y; Wei H; Chen J; Ji M
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1109-16. PubMed ID: 19555174
[TBL] [Abstract][Full Text] [Related]
13. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
14. QSAR study on 5-lipoxygenase inhibitors based on support vector machine.
Niu B; Su Q; Yuan X; Lu W; Ding J
Med Chem; 2012 Nov; 8(6):1108-16. PubMed ID: 22779798
[TBL] [Abstract][Full Text] [Related]
15. Determining the validity of a QSAR model--a classification approach.
Guha R; Jurs PC
J Chem Inf Model; 2005; 45(1):65-73. PubMed ID: 15667130
[TBL] [Abstract][Full Text] [Related]
16. Molecular connectivity indices for predicting bioactivities of substituted nitrobenzene and aniline compounds.
Lin KH; Jaw CG; Yen JH; Wang YS
Ecotoxicol Environ Saf; 2009 Oct; 72(7):1942-9. PubMed ID: 19423164
[TBL] [Abstract][Full Text] [Related]
17. QSAR study of heparanase inhibitors activity using artificial neural networks and Levenberg-Marquardt algorithm.
Jalali-Heravi M; Asadollahi-Baboli M; Shahbazikhah P
Eur J Med Chem; 2008 Mar; 43(3):548-56. PubMed ID: 17602800
[TBL] [Abstract][Full Text] [Related]
18. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
[TBL] [Abstract][Full Text] [Related]
19. Exploration of QSAR modelling techniques and their combination to rationalize the physicochemical characters of nitrophenyl derivatives towards aldose reductase inhibition.
Soni LK; Gupta AK; Kaskhedikar SG
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1002-7. PubMed ID: 19514863
[TBL] [Abstract][Full Text] [Related]
20. QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
Sabet R; Fassihi A; Moeinifard B
J Mol Graph Model; 2009 Sep; 28(2):146-55. PubMed ID: 19570701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
